A systematic review of 63 cases finds that pyoderma gangrenosum in pregnancy is frequently misdiagnosed.

InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its cash runway.

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to the drawing board.

Nachrichten INFLARX AKTIE » InflaRx N.V.: InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum ...

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: “We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this ...

Also known as pyoderma faciale, rosacea fulminans manifests as flushed, swollen, and painful nodules and pimples that can merge. These symptoms differ from those of rosacea or acne in that they ...

SPOKANE, Wash. – Ryan Becker, a Spokane resident, is battling an extremely rare skin condition known as pyoderma gangrenosum.

Infertility is common, and the age of the female partner is the main predictor of live birth. Reproductive issues in men are common and can be effectively managed. In vitro fertilization is highly ...

Pyoderma, an infection of the skin, is a common bacterial disease of dogs. Learn about the causes, symptoms, and treatment options for this condition today.

Some cases traditionally identified as pyoderma gangrenosum (PG) in patients with certain blood diseases may actually be another rare autoimmune condition, suggest researchers. Publishing their ...